Editorial: Targeting Myeloid Cells to Fight Cancer

Editorial: Targeting Myeloid Cells to Fight Cancer

Bibliographic Details
Main Authors:	Maija Hollmén, Wei Zheng, Jeffrey W. Pollard
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Immunology
Subjects:	tumor microenvironment monocyte macrophage neutrophil immunosuppression immunotherapy
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2019.02835/full

Similar Items

The Role of Myeloid Cells in GBM Immunosuppression
by: Ya-Jui Lin, et al.
Published: (2022-05-01)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
by: Yan Tie, et al.
Published: (2022-05-01)

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
by: Mahmoud S. Alghamri, et al.
Published: (2021-05-01)

Targeting the myeloid microenvironment in neuroblastoma
by: Marjolein C. Stip, et al.
Published: (2023-12-01)

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
by: Jianmei W. Leavenworth, et al.
Published: (2022-12-01)

Editorial: Hallmark of cancer: avoiding immune suppression
by: Faris Q. B. Alenzi, et al.
Published: (2023-06-01)

Cancer-associated myeloid regulatory cells
by: Yannick eDe Vlaeminck, et al.
Published: (2016-03-01)

Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
by: Céline Blaye, et al.
Published: (2022-03-01)

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
by: Emile J. Clappaert, et al.
Published: (2018-10-01)

Interactions between immunosuppressor neutrophiles, innate and adaptive immunity indexes in the patients with subclinical atherosclerosis
by: I. I. Dolgushi, et al.
Published: (2022-04-01)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
by: Julie Decock, et al.
Published: (2023-05-01)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
by: Viktor Fleming, et al.
Published: (2018-03-01)

Nanomaterials: small particles show huge possibilities for cancer immunotherapy
by: Ziyin Chen, et al.
Published: (2022-11-01)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
by: Yu Saida, et al.
Published: (2023-07-01)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
by: Julie Giraud, et al.
Published: (2021-03-01)

Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy
by: Tiziana Cotechini, et al.
Published: (2021-04-01)

Heterogeneous Myeloid Cells in Tumors
by: Aixia Dou, et al.
Published: (2021-07-01)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01)

The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma
by: Lingyun Zhang, et al.
Published: (2023-09-01)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
by: Shifen Wang, et al.
Published: (2023-03-01)

The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment
by: Lunxu Li, et al.
Published: (2023-05-01)

The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer
by: Hoda T. Amer, et al.
Published: (2022-11-01)

Monocytes in Tumorigenesis and Tumor Immunotherapy
by: Xiaodie Chen, et al.
Published: (2023-06-01)

Immunotherapy Targeting Tumor-Associated Macrophages
by: Yafei Liu, et al.
Published: (2020-11-01)

Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
by: Julie G Grossman, et al.
Published: (2018-09-01)

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
by: Reem Saleh, et al.
Published: (2020-07-01)

T lymphocyte cell: A pivotal player in lung cancer
by: Yanan Wu, et al.
Published: (2023-01-01)

Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy
by: Sanjana Rajgopal, et al.
Published: (2023-12-01)

Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
by: Yushan Dong, et al.
Published: (2023-11-01)

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer
by: Yanan Wu, et al.
Published: (2023-02-01)

The Monocytes That Repopulate in Mice After Cyclophosphamide Treatment Acquire a Neutrophil Precursor Gene Signature and Immunosuppressive Activity
by: Zhi-Chun Ding, et al.
Published: (2021-01-01)

Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy
by: Zi-Xuan He, et al.
Published: (2022-01-01)

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
by: Shuang Guo, et al.
Published: (2022-09-01)

Revealing Pan-Histology Immunomodulatory Targets in Pediatric Central Nervous System Tumors
by: Robert T. Galvin, et al.
Published: (2023-11-01)

Exploring the function of myeloid cells in promoting metastasis in head and neck cancer
by: Dakota Dike Dimegwu Okwuone, et al.
Published: (2024-02-01)

Nanomaterials: A powerful tool for tumor immunotherapy
by: Ziyin Chen, et al.
Published: (2022-08-01)

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy
by: Meng-Qi Liu, et al.
Published: (2023-12-01)

Neutrophil: A New Player in Metastatic Cancers
by: Mengyue Wu, et al.
Published: (2020-09-01)

The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
by: Mengyuan Li, et al.
Published: (2023-02-01)